The whole capitalist system is full of “middlemen”. Big government is also full of “middlemen”. Not sure where that is going.
Whatever they do I hope they don’t squash the incentives for research and development of new drugs which is a risky enterprise and has to be paid for somehow.
Sure but distribution in the pharma industry is exceptionally concentrated - 90% of all drugs are supplied by either AmerisourceBergen, Cardinal Health, and McKesson.
And that’s just the top tier of distribution.